Company profile: Lisapharma
1.1 - Company Overview
Company description
- Provider of sterile injectable medicines and contract manufacturing for sterile and non-sterile products (liquids, semi-solids, medical devices). Offers pharmacovigilance; R&D (analytical method development, forced degradation, product characterization, stability); and quality control (chemical-physical, microbiological, packaging analysis). Acurmil (Atracurium Besilate) IV injectable muscle relaxant. Based in Erba, Italy; active in 40+ countries.
Products and services
- Contract Manufacturing: Delivers industrial-scale contract manufacturing for sterile and non-sterile products, covering liquids, semi-solids, and medical devices across defined formulation categories
- Research and Development: Develops analytical-grade R&D programs, including analytical method development, forced degradation studies, drug product characterization, and stability studies to underpin robust drug product performance
- Sterile Injectable Medicines: Engineers and produces sterile-class injectable drugs across various therapeutic areas, combining production and development of injectable formulations to meet rigorous sterility requirements
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Lisapharma
Locust Walk
HQ: United States
Website
- Description: Provider of strategic partnering and M&A services, facilitating licensing and acquisition deals in the USA, Europe, Japan, and China. Offers capital raising and underwriting, including private placements, IPO advisory, and SPAC advisory. Delivers strategy consulting and analytics for partnering, M&A, and fundraising. Conducts rigorous due diligence via internal committee and external scientific advisory board.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Locust Walk company profile →
ABL
HQ: United States
Website
- Description: Provider of biotechnology contract research, development, and manufacturing services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ABL company profile →
Leinco Technologies
HQ: United States
Website
- Description: Provider of monoclonal antibodies and protein tools for life science research, diagnostics, therapeutics, and flow cytometry, including primary, secondary, and in vivo functional grade antibodies; PhenoCycler-Fusion barcoded antibodies; flow cytometry reagents; recombinant proteins; streptavidin products; and cytokines to support early discovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Leinco Technologies company profile →
Magle Chemoswed
HQ: Sweden
Website
- Description: Provider of integrated pharmaceutical development and GMP-compliant manufacturing from pre-clinical to commercial scale, including inhalation services (dry powder formulation, micronization, crystallinity restoration), solid-state analysis and characterization (polymorph and salt screening), analytical method development and validation, organic chemistry process development, crystallization support, and batch release testing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Magle Chemoswed company profile →
Quartesian
HQ: United States
Website
- Description: Provider of biostatistics, programming, and medical writing services, delivering customized, insightful data to organizations performing clinical studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Quartesian company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Lisapharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Lisapharma
2.2 - Growth funds investing in similar companies to Lisapharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Lisapharma
4.2 - Public trading comparable groups for Lisapharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →